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Abstract: dUTPase is an enzyme found in all organisms that have thymine as a constituent of DNA.
Through evolution, humans have two major isoforms of dUTPase: a mitochondrial (mDut) and a nuclear
(nDut) isoform. The nuclear isoform of dUTPase is a 164-amino-acids-long protein containing three cys-
teine residues. nDut’s starting methionine is post-translationally cleaved, leaving four unique amino
acids on its amino-terminus including one cysteine residue (C3). These are not present in the mitochon-
drial isoform (mDut). Using mass spectrometry analyses of recombinant dUTPase constructs, we have
discovered an intermolecular disulfide bridge between cysteine-3 of each nDut monomer. We have
found that these two residues stabilize a dimer configuration that is unique to the nDut isoform. We have
also uncovered an intramolecular disulfide linkage between cysteine residues C78 and C134, stabilizing
the monomeric state of the protein. Of note, both disulfide linkages are essential for nDut’s enzymatic
activity and dimeric formation can be augmented by the addition of the oxidizing agent, hydrogen perox-
ide to cells. Analyses of endogenous cellular dUTPase proteins confirm these differences between the
two isoforms. We observed that mDut appears to be a mixture of monomer, dimer, and trimer conforma-
tions, as well as higher-order subunit interactions. In contrast, nDut appeared to exist only in monomeric
and dimeric forms. Cysteine-based redox “switches” have recently emerged as a distinct class of post-
translational modification. In light of this and our results, we propose that nDut possesses a redox
switch whereby cysteine interactions regulate nDut’s dUTP-hydrolyzing activity.
Abbreviations: mDut, mitochondria dUTPase isoform; nDut, nuclear dUTPase isoform; BME, beta mercaptoethanol; DTT, dithio-
threitol; C3, Cysteine 3; C78, Cysteine 78; C134, Cysteine 134; C3A, Cysteine 3 to alanine mutation; C78A, Cysteine 78 to alanine
mutation; C134A, Cysteine 134 to alanine mutation; S11A, Serine 11 to alanine mutation; S11D, Serine 11 to aspartic acid muta-
tion; IPTG, isopropyl beta-D-1-thiogalactopyranoside; MALDI, TOF-matrix-assisted laser desorption/ionization time-of-flight; CHCA,
alpha-cyano-4-hydroxycinnamic acid; TFA, trifluoroacetic acid.
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Broader word statement
Genomic integrity depends on repairing damaged bases
as well as preventing incorporation of inappropriate
deoxynucleotides. dUTPase is an enzyme that hydro-
lyzes dUTP to dUMP, preventing misincorporation of
this base. It also provides substrate for de novo thymi-
dylate synthesis. Our present work uncovers disulfide
linkages in the nuclear dUTPase. These consist of both
inter- and intra-cysteine disulfide bonds. Disruption of
these linkages leads to dUTPase inactivity. This leads
us to propose that this modification may act as a redox
switch controlling enzyme activity.
Introduction
Maintaining genomic stability is vital for cell sur-
vival. This entails the need for a proper balance of
nucleotides for DNA replication and repair. dUTPase
is one of the many enzymes which ensures that the
integrity of the genome is maintained. It catalyzes
the hydrolysis of dUTP to dUMP and pyrophosphate.1
This reaction is beneficial in two ways: (i) it precludes
the buildup of dUTP pools that could otherwise lead
to unwanted incorporation of dUMP into DNA and
(ii) it provides the substrate for the de novo synthesis
of TMP.2,3 dUTPase is an essential gene that is found
in all organisms that have thymine as a genomic
constituent.
Structurally, dUTPases can be divided into three
classes, monomeric, dimeric, and trimeric enzymes.4
The monomeric forms reside largely within mamma-
lian and avian herpesviruses.5 The homodimeric
enzymes are present in trypanosomes, certain bacte-
ria, and bacteriophages.6,7 The homotrimeric family
is the largest and are found in certain retroviruses
and in prokaryotes, as well as eukaryotic cells.4 In
addition to the role of dUTP hydrolysis, dUTPases
have been implicated in distinct signaling pathways.8
Other reports have indicated that the dUTPase
enzyme from the Epstein–Barr virus can act as a
pathogen-associated molecular pattern protein and
can function in immunomodulation.9,10
In Homo sapiens, the dUTPase gene codes for
multiple isoforms. The most prominent forms are a
nuclear isoform and a mitochondrial isoform: nuclear
(nDut) and mitochondrial (mDut).11 Due to the alter-
native use of exons, both proteins contain a unique
amino-terminal region while sharing a common
carboxyl-terminal domain.2,11 Multiple crystal struc-
tures are available for the human dUTPase enzyme,
all of which report a trimeric conformation with three
active sites.3,12–14 These active sites are formed with
a combination of the five conserved dUTPase
motifs.3,4,14 Each active site itself contains Motifs
1, 2, and 4 from one monomer, Motif 3 from the sec-
ond monomer and Motif 5 from the third.4 The over-
all tertiary structure of each subunit is composed of
antiparallel beta sheets.4
Recently, the flexible C-terminal segment of
dUTPase has been crystallized, demonstrating its
role in the enzymatic activity of the protein.14 How-
ever, a feature common to all current crystal struc-
tures is the lack of detail pertaining to the N-
terminal arm (Amino acids 1–23 in reference to the
nuclear isoform). Also, a secondary finding reported
with two of the structures, is the appearance of an
asymmetric trimer conformation (1Q5U and 2HQU)
where two of the three monomers are more tightly
associated.3,14
The work presented here largely focuses on nDut,
in which the starting methionine is post-
translationally cleaved, leaving only four unique
amino acids in the amino-terminus when compared
with mDut, including one cysteine residue (C3).15
Results indicate that there is an intermolecular disul-
fide bridge between the two cysteines at Position 3 of
each monomer. These residues stabilize a dimer con-
figuration that is unique to the nDut isoform. A sec-
ond disulfide bridge has been identified through mass
spectrometry analysis between cysteine Residues
78 (C78) and 134 (C134) that stabilize each mono-
meric subunit.
Finally, we demonstrate that both disulfide brid-
ges are essential for enzymatic activity. In addition,
the dimeric state of nDut can be modulated by the
addition of the oxidizing agent hydrogen peroxide or
the reducing agent beta-mercaptoethanol (BME).
Interestingly, recent reports have now identified an
additional category of post-translational modifica-
tions termed cysteine-based “redox switches.”16 In
light of these discoveries, it is possible that nDut
may be a part of this enzymatic class. In which,
nDut’s enzymatic activity is regulated through its
redox potential exhibiting “high” enzymatic activity
in the oxidized state and “low” activity in the
reduced state.
Results
Demonstration of a disulfide linkage in the
human nuclear isoform of dUTPase
The serendipitous omission of a reducing agent from
an SDS-PAGE/western blot analysis of total cell
extracts led us to the finding that the nuclear isoform
of dUTPase contains a disulfide linkage. This linkage
appears to be between two monomers forming an
apparent dimer complex. The intensity of this
1798 PROTEINSCIENCE.ORG Human ndUTPase Intra- and Intermolecular Disulfide Bonds
multimeric complex seems to vary in the cell lines
examined. An asynchronous population of the human
osteosarcoma cell lines (U-2 OS and Saos2), a human
epithelial lung carcinoma cell line (A549), and a
human colon fibroblast cell line (18 Co) were
extracted in the presence of the alkylating agent,
iodoacetamide. This agent was used to negate non-
specific disulfide linkages during protein extraction of
these cells (Fig. S1). As illustrated in Figure 1(A), a
multimeric complex indicative of a dimer is observed
(indicated by the black box). This then disappears
with the addition of the reducing agent, BME [Fig. 1
(B)] indicating the presence of a disulfide linkage.
There are multiple reported isoforms of human
dUTPase. The most prominent forms are a nuclear
isoform and a mitochondrial isoform.11 nDut contains
three cysteine residues, Cysteine 3, 78 and 134. C3 is
unique to nDut when compared to its mitochondrial
counterpart and is located within the flexible
n-terminal region of the protein. Whereas C78 and
C134 are both located within the protein core approx-
imately 4 Å apart from one another in the tertiary
structure.3 All three cysteine residues are found
outside of the five highly conserved dUTPase motifs.4
The mitochondrial isoform has two cysteines at posi-
tions 97 and 153 (based on the mature, processed
dUTPase sequence) which are equivalent to the
nuclear C78 and C134. A third isoform has been
reported to begin at an internal methionine that we
have annotated as M24 using the nDut sequence as a
reference (NCBI: Accession no. 001025249).
To determine if the mitochondrial isoform con-
tains a disulfide linkage, mitochondria were isolated
from U-2 OS and a western blot analysis was per-
formed on proteins separated by SDS-PAGE in the
presence and absence of BME. This was then com-
pared to whole cell extracts. As shown in Figure 1(C),
it does not appear that mDut forms a multimeric
complex through disulfide interactions under these
conditions. Considering the fact that all three iso-
forms contain two of the three cysteine residues but
only nDut contains C3, we conclude that C3 is the
likely candidate involved in disulfide bond formation
leading to the apparent dimer formation. We per-
formed further experimental work to establish the
existence of disulfide linkages in the nDut isoform.
Figure 1. Demonstration of intermolecular disulfide bond formation in the nuclear dUTPase protein. (A) A western blot analysis of
total cell extracts (TCE) in the absence of the reducing agent, beta-mercaptoethanol (BME) demonstrates a multimeric complex
formation in asynchronous populations of U-2 OS, Saos2, A549, and 18CO as indicated by the black box. This complex
disappears with the addition of BME in all four cell lines examined. (B) The lower panel in both A and B are exposed to X-ray film
for 10 s to demonstrate the monomeric state of the three isoforms of dUTPase. The upper panels are exposed to X-ray film for
1 min. (C) A western blot analysis of TCE and purified mitochondrial extracts (Mito), as indicated, derived from U-2 OS cells ()
BME shows no multimeric complex formation in the –BME Mito sample. The lower panel is exposed to X-ray film for 10 s while
the upper panel is exposed to X-ray film for 2 min. Equivalent amounts of protein were applied to each lane. Blots were probed
with a polyclonal specific antibody against the conserved carboxyl-terminal domain of dUTPase. The lower molecular weight band
observed in (A) and (B) is likely a truncated form of dUTPase (M24) (Fig. S3).
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Identification of the cysteine residues in nuclear
dUTPase that form a disulfide linkage
With the novel finding that nDut forms a stable mul-
timeric complex through a disulfide linkage, the next
logical step was to elucidate which cysteine residues
may be involved. Site-directed mutagenesis of each of
the three cysteine residues to alanine was performed.
Two sets of three single-mutant constructs (C3A,
78A, and C134A) and one double-mutant construct
(C78:134A) were engineered containing either a hexa-
histidine C-terminal tag (.Ctag) [Fig. 2(A) and (C)] or
a hexahistidine N-terminal tag (.Ntag) [Fig. 2(B) and
(D)]. The constructs were transiently transfected into
U-2 OS cells for 24 h. Post-transfection the cells were
harvested and total cell extracts were prepared.
Equivalent amounts of protein were run in an SDS-
PAGE gel () BME as indicated. Western blot analy-
sis was performed probing for the hexahistidine affin-
ity tag. The results demonstrate that the C3A single-
point mutant disrupts the multimeric complex of
nDut. As shown in Figure 2, the location of the
histidine-tag has no effect on the ability of nDut to
form a multimeric complex. The single-mutant C-78A
and the double-mutant construct (C78:134A) retain
the ability to form a multimeric complex, similar to
Wt nDut. The C134A mutant still retains the ability
to form the multimeric complex but appears less sta-
ble as implicated by the decrease in signal for the
complex. This experiment does not negate the notion
that C78 and C134 may have an important role in
stabilizing the monomeric state of the protein. When
the amino acids are substituted with an alanine it is
possible that the folding of the monomeric protein is
affected leading to a less stable protein. There is also
an observed heterogeneity of the nDut signal in the
immunoblots [Fig. 2(A) and (C)]. This may be attrib-
uted to an internal start site located at Methionine
24, resulting in a truncated product (M24.Dut;
Fig. S3), as discussed earlier. When the tag is located
on the N-terminus this heterogeneity is not seen
[Fig. 2(B,D)]; again supporting the notion of an inter-
nal start site. What can be concluded from this data
is that the nDut isoform is able to form a multimeric
complex and the cysteine residue at position 3 of the
primary sequence is likely responsible for complex
formation.
Escherichia coli expressed recombinant nuclear
dUTPase verifies the C3–C3 disulfide linkage
formation
In order to further understand the structural charac-
teristics of nDut’s multimeric nature, Wt and the cys-
teine to alanine mutants of nDut were expressed in
E. coli and purified by nickel-chelate affinity chroma-
tography. As shown in Figure 3, protein analysis by
SDS-PAGE without BME demonstrates the existence
of disulfide linkages in recombinant nDut. The pat-
tern of complex formation of each recombinant
Figure 2. Cysteine 3 is a critical residue in stabilizing the secondary structure of nuclear dUTPase. The expression of nDut.Ctag,
nDut.Ntag and cysteine to alanine mutants in U-2 OS cells implicate C3 as a critical residue in stabilizing the higher order
structure of n.Dut. Two constructs of each set of proteins contained either a hexahistidine C-terminus tag (A, C) or hexahistidine
N-terminus tag (B, D). 3 μg of each plasmid were transiently transfected into U2-OS cells followed by a 24-h incubation. The cells
were harvested and 20 μg of total cell extract was applied to a 4–20% tris-glycine SDS-PAGE () BME as indicated. Western blot
analysis was then preformed using a histidine primary antibody. The predicted molecular weight of nDut.Ntag is 21,188 Da. This
includes the existence of a 28 amino acid leader sequence (3458 Da). The nDut.Ctag construct is void of this leader sequence and
is predicted to be 18,571 Da. The lower molecular weight band observed in (A) and (C) is likely a truncated form of dUTPase (M24)
(Fig. S3).
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protein is similar to what is observed in the mamma-
lian expression system, discussed previously. The C3A
mutants lack the ability to form any multimeric com-
plexes. While both the single mutants (C78 and C134)
are similar to Wt, the double mutant (C78:134A)
appears to be more monomeric. This may be due to
the additive effects of the mutations possibly disrupt-
ing the folding of the monomeric state of the protein,
which could then lead to a less stable form, preventing
the multimeric complex to form as efficiently.
With the previous knowledge that nDut is phos-
phorylated on Serine 11,15,17 we set out to determine
if phosphorylation altered the formation of the multi-
meric complex. A phosphomimetic (S11D) and a phos-
phorylation blocking (S11A) mutant were expressed
in E. coli and purified by nickel-chelate affinity chro-
matography. As shown in Figure S4, protein analysis
by SDS-PAGE with and without BME demonstrates
no apparent difference between the two mutants
when compared with Wt. Leading to the conclusion
that phosphorylation does not influence complex
formation.
Mass spectrometry supports the finding of a C3–
C3 disulfide linkage and uncovers a C78–C134
intramolecular disulfide linkage
To further define the molecular weight of the multi-
meric complex of nDut that is shown in the previous
results, MALDI-TOF mass spectrometry was uti-
lized. Upon analysis of the full-length recombinant
nDut.Ntag, a peak was observed that corresponds to
the expected molecular mass of the dimeric (42 kDa)
form of the protein [Fig. 3(D)] which correlates well
to the relative molecular weight observed on the
SDS-PAGE gels. To further clarify that this dimeric
conformation was due to an intermolecular disulfide
linkage between two cysteine 3 residues, a full-
length C3A mutant was analyzed [Fig. 3(E)]. The
results of this spectrum show what is classically
exhibited for a monomeric protein. In this case, a
single peak corresponding to 21 kDa [Fig. 3(E)] is
observed with a second less intense peak that can be
attributed to non-covalent interactions. These
results suggest that nDut contains an intermolecu-
lar disulfide bridge between two distinct Cysteine
Figure 3. An intermolecular disulfide bridge formation between two cysteine 3 residues is essential for nuclear dUTPase dimer
formation. A 12% Tris-Glycine SDS-PAGE coomassie stained gel of recombinant Wt nDut.Ntag and cysteine to alanine mutants in
(A) non-reducing (-BME) or (B) reducing conditions (+BME). (C) A 16% Tris-Glycine SDS-PAGE coomassie stained gel of
recombinant Wt nDut.Ctag (+/-) BME. Predicted molecular weights and migration behavior on SDS-PAGE is reflective of what is
seen in Figure 2. Mass spectrometry was performed with 2 μg of both the full length Wt nDut.ntag (D) and the C3A mutant (E). The
peak of interest corresponds to the dimeric (42 KDa) state of the protein which can be visualized in the Wt (D) spectrum. As
shown, this peak is significantly diminished in the C3A spectrum.
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3 residues that covalently stabilize the dimeric state
of the protein.
To further confirm the existence of the C3–C3
disulfide bridge MALDI-TOF mass spectrometry was
performed using the Wt nDut.Ctag recombinant pro-
tein. The Wt nDut.Ctag was alkylated with iodoaceta-
mide, followed by a trypsin-digestion, and then
subjected to MALDI-TOF mass spectrometry. The
results show an observed peak at 3000.6 Da, a mass
which corresponds to the predicted polypeptide frag-
ment (3001.5 Da) of two-linked nDut trypsin digested
fragments (PCSEETPAISPSKR) containing the C3
residue (R1-S-S-R1) [Fig. 4(A)], both lacking the first
methionine residue. In-source decay (ISD) was used
to confirm that the recombinant protein, as reported
with the endogenous protein,15 also lacked the
Figure 4. Nuclear dUTPase contains both intramolecular and intermolecular disulfide bridges. (A) 20 μg of recombinant n.Dut.Ctag
was alkylated with iodoacetamide for 20 min followed by a 3 h trypsin digestion at 37C. Mass spectrometry analysis was
performed on the tryptic fragments. A peak was observed at 3000.6 Da which corresponds to the expected molecular mass of
two-linked intermolecular n.Dut tryptic digested fragments containing the cysteine 3 (C3) residue. A second peak was observed at
2436.3 Da which corresponds to the expected molecular mass of two linked tryptic fragments that include cysteine residues
78 and 134. (B) MS/MS analysis verified that the 3000.9 Da peak disassociates into a triple peak at the observed molecular
weights of 1467.1, 1501.1, and 1533.0 Da which corresponds to the symmetric and asymmetric cleavage of the disulfide bond
that linked the two C3 peptides with a mass separation of approximately 32–34 Da. (C) 20 μg of recombinant n.Dut.ntag was
alkylated with iodoacetamide for 20 min followed by an overnight trypsin digestion at 37C. Mass spectrometry analysis was
performed on tryptic fragments. A peak was observed at 2435.8 Da which corresponds to the expected molecular mass of two
linked tryptic fragments that include cysteine residues 78 and 134. (D) MS/MS analysis demonstrated the disassociation of that
fragment into two distinct species, each containing three peaks which correspond to the symmetric and asymmetric cleavage of
the disulfide bond that linked the two peptides. The C78 containing tryptic fragment are clustered at 1459.7, 1493.3, and
1525.7 Da and the C134 containing tryptic fragment are clustered at 911.5, 945.4, and 977.6 Da with a mass separation between
each of the peaks of approximately 32–34 Da. The observed peak at 2281.2 Da corresponds to the two linked tryptic fragments
observed at 2436.6 Da lacking the weight of one arginine atom (156 Da). In panels A and C, the additional tryptic fragments that
are labeled are identified as n.Dut and can been found in Figure S5.
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starting methionine residue (data not shown). To ver-
ify this intermolecular disulfide bridge, MS/MS analy-
sis of this peak was performed. This analysis shows
the dissociation of this fragment into a cluster of
three individual peaks, corresponding to the symmet-
ric and asymmetric cleavage of the disulfide bond
that linked the peptide with a mass separation of
approximately 32–34 Da18,19 [Fig. 4(B)]. These results
are in agreement with previous data showing the
existence of an intermolecular disulfide bridge
between two monomeric proteins through two C3 res-
idues which stabilize the dimeric state of nDut.
The second observation of an intramolecular
disulfide bridge was made while utilizing MALDI-
TOF mass spectrometry for Wt nDut.Ctag, as well as
Wt nDut.Ntag. Under optimized conditions, a peak
was observed corresponding to the mass of two-linked
nDut trypsin-digested fragments containing the C78
and the C134 residue (R2-S-S-R3) [Fig. 4(A) and (C)].
What was not observed in either spectra were any
peaks that corresponded to a disulfide bond between
fragments R1-S-S-R2, R2-S-S-R2, R1-S-S-R3, or R3-S-
S-R3. MS/MS analysis of the R2-S-S-R3 peak for Wt
nDut.Ntag showed the dissociation of the fragment
into two clusters, each with three individual peaks,
corresponding to the symmetric and asymmetric
cleavage of the disulfide bond that linked the two
peptides18,19 [Fig. 4(D)]. Together these results indi-
cate the existence of an intramolecular disulfide link-
age between cysteine Residues 78 and 134, which
likely stabilize the monomeric state of the protein.
Implication of disulfide linkage formation in
nuclear dUTPase enzymatic activity
dUTPase plays an essential role in DNA replication
and repair. It catalyzes the hydrolysis of dUTP to
dUMP + PPi resulting in the decrease of intracellular
concentrations of dUTP availability, thus preventing
its incorporation into DNA.1 To investigate the possi-
ble roles that the three cysteine residues may have
on this enzymatic function, a dUTPase enzymatic
assay was used.1 Recombinant nDut.Ntag hydrolyzed
7.27 pmol of dUTP per minute per ng of protein [Fig. 5
(A)], which is consistent with previously reported
enzymatic activity of endogenous dUTPase.1,20 The
enzymatic activity of all mutants decreased when
compared with Wt [Fig. 5(A)].
This assay was then repeated using the Wt
recombinant protein in the presence of the reducing
agent BME [Fig. 5(B)]. As shown in the figure, the
presence of a reducing agent drastically reduces
enzyme activity, corroborating results presented with
the cysteine to alanine mutants. These data show
that the cysteine residues are essential for the enzy-
matic activity, most likely due to the disulfide link-
ages they form, leading to the stabilization of the
overall structural integrity of the protein.
Exploration of higher order subunit interaction of
the dUTPase protein
Several crystallographic studies of the human dUT-
Pase protein indicate that this protein forms a
trimer.3,12–14 A number of these studies analyze a
truncated recombinant protein that is missing the
first 23 amino acids or perform crystallization in the
presence of reducing agents.3,12–14 Under reducing
conditions the amino-terminal 23 amino acids would
be unstructured and therefore would not appear in
the crystal structure. In an effort to determine if a tri-
meric dUTPase forms in the conditions of our analy-
sis, we performed formaldehyde cross-linking studies
with both the mitochondrial and nuclear isoforms of
dUTPase purified from U-2 OS and HeLa cells.
Figure 6 presents data indicating that the mitochon-
drial version of dUTPase appears as a mixture of
monomer, dimer, and trimer, as well as higher-order
subunit interactions. In contrast, nDut produces pre-
dominantly monomeric and dimeric proteins as the
dominant species. These results allude to the possi-
bility that the two isoforms function as distinct struc-
tural entities.
Figure 5. Cysteine residues 3, 78, and 134 play an essential
role in nuclear dUTPase activity. Each protein was assayed at
37C for 5 min. The average pmol of dUMP formed per minute
per nanogram of protein was then plotted on the y-axis. (A) A
substitution of cysteine residues for alanine residues affects
the enzymatic activity of nuclear dUTPase, possibly due to
disruption of disulfide bonds. Each bar represents an n of
9. (B) Wt n.Dut’s enzymatic activity decreases in the presence
of the reducing agent BME. All samples for this experiment
were allowed to incubate on ice for 15 min with or without 2%
BME before performing the assay. Then an additional 2% BME
was added directly to the enzyme assay mixture for the
indicated samples. Each bar represents an n of 3. All assays
were performed at saturating substrate concentrations. Assays
were performed in the linear range for both time and protein
concentration, based on Wt protein assays. The graphs were
generated using GraphPad (La Jolla, CA).
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Consequences of cellular oxidative stress on
nDut dimer formation
Thiols in cysteine residues in proteins are among the
most oxidant-sensitive targets and can undergo vari-
ous alterations in response to reactive oxygen spe-
cies.21 In an effort to determine if elevated oxidation
affects disulfide bond formation in nDut, in particular
dimerization, cells in culture were exposed to varying
concentrations of hydrogen peroxide for an 18-h
period. As seen in Figure 7, there is a four- to five-fold
increase in dimer formation as a consequence of
hydrogen peroxide exposure. This assay, however,
cannot decipher between the oxidized or reduced
forms of the monomeric protein. The results outlined
in Figure 5 demonstrate that both the C3–C3 inter-
molecular disulfide bond formation as well as the
C78-C134 intramolecular disulfide bond formation
are critical for dUTPase activity. Based on these
results, it can be inferred that cellular oxidative
stress can augment disulfide bond formation in the
dUTPase protein and presumably elevate dUTP-
hydrolyzing activity.
Discussion
The omission of a reducing agent from an SDS-
PAGE/western blot analysis of total cell extract fol-
lowed by mass spectrometry analysis led us to the
finding that nDut contains an intermolecular disul-
fide bond between C3 residues of two monomers form-
ing a dimer. This dimer configuration is unique to the
nDut isoform and is essential for its enzymatic activ-
ity. To ensure that the nDut dimer species presented
Figure 6. Formaldehyde cross-linking of mitochondrial and nuclear dUTPase demonstrate distinct structural entities for each
isoform. (A) HeLa cells and (B) U-2 OS were incubated with formaldehyde as described in materials and methods. Nuclei (N) and
mitochondria (M) were isolated then analyzed by western blot using a specific polyclonal antibody against the conserved
carboxyl-terminal domain of dUTPase (+ formaldehyde). To reverse the formaldehyde cross-links, extracts derived from both the
nuclear and mitochondrial preparations were mixed with SDS-PAGE buffer then heated to 98C for 15 min in the presence of BME
(+ formaldehyde 98C/15 min). The observed heterogeneity (i.e. doublet bands of nDut) seen with the preparations remain to be
explained, but may be due to anomalous migration due to the formaldehyde treatment. Both lower panels in A are exposed to X-
ray film for 10 s while B and the upper panels in A are exposed to X-ray film for 2 min.
Figure 7. Hydrogen peroxide exposure of cells results in elevated nDut dimer formation. HeLa and U-2 OS cells were exposed to
the indicated concentrations of hydrogen peroxide for 18 hours. Cells were harvested followed by protein extraction. 20 μg of
protein derived from total cell extract were applied to a 16% SDS-PAGE gel in the absence of the reducing agent, beta-
mercaptoethanol (BME), followed by a western blot analysis probed with a specific polyclonal antibody against the conserved
carboxyl-terminal domain of dUTPase. The position of dimer is indicated. The upper blots were exposed to X-ray film for 1 min,
the lower blots for 10 s. There is a four- to five-fold increase in dimer formation as a function of increasing hydrogen peroxide
concentration. ImageJ software was utilized to quantitate band intensity of the dimer.
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in our studies is an accurate representation of the
endogenous conformational state of the protein and
not a consequence of the extraction procedure, iodoa-
cetamide was added directly to the extraction buffer.
Our data demonstrate that the C3–C3 disulfide link-
age is present post-treatment. It is thought that the
overall intracellular environment is in a reducing
state,22 however, it is well documented that micro-
environments exist favoring an oxidized state and thus
favoring disulfide bond formation intracellularly.23
A second disulfide bridge has been identified
through mass spectrometry between cysteine resi-
dues 78 and 134. These two cysteine residues are
located proximal to one another in each monomeric
subunit. By disrupting this intramolecular disulfide
bridge, the folding of each monomeric protein may be
compromised destabilizing the monomeric unit,
which then leads to a decrease in enzymatic activity.
Each of these disulfide bonds (i.e. C3–C3 and C78–
C134) may be regulated differentially by the microen-
vironment. Further work is needed to elucidate the
extent of inter- versus intramolecular disulfide bond
formation.
Several reports indicate that nDut is a homotri-
meric protein.3,12–14 Results reported here indicate
that only monomeric and dimeric forms are preva-
lent. It seems feasible that the trimeric state of nDut
may be stabilized through both covalent and noncova-
lent interactions. The dimer first forms through the
C3–C3 intermolecular disulfide bridge and then tri-
mer formation occurs through non-covalent interac-
tions between the dimer and a monomer. In an
attempt to uncover a trimeric dUTPase, we utilized
cross-linking with formaldehyde. Using this reagent,
we analyzed both the nuclear and mitochondrial iso-
forms of dUTPase. mDut appears as a mixture of
monomer, dimer, and trimer, as well as higher-order
complexes. In contrast, nDut appears to be only in
monomeric and dimeric forms. We believe that this
difference in structural conformation is due to the
unique N-terminal domains of each isoform. The dis-
crepancies between this report and the crystal struc-
tures may be due to the stringent conditions needed
for crystallization. Future crystallization efforts with
the C3–C3 disulfide bond intact may reveal a novel
structure for the nDut isoform.
There are slight differences in enzymatic activity
between the C-terminal and N-terminal tagged con-
structs. The decreased enzymatic activity displayed
with Wt nDut.Ctag when compared with the N-
tagged construct may be attributed to the location of
the poly-histidine tag. Domain 5 which is located in
the flexible C-terminus tail is thought to be needed
to “cap” the active site through multiple interactions
with the other domains.14 It is possible that the addi-
tion of the tag may have decreased the flexibility of
the C-terminus making these interactions less
stable.
Interestingly, recent reports have now identified
an additional category of post-translational modifica-
tions termed cysteine-based “redox switches”.16 There
have been significant strides in understanding this
modification. Taking these findings into account, it is
conceivable that nDut may now be considered a mem-
ber of this enzymatic class, where its enzymatic activ-
ity is regulated through its redox potential,
exhibiting “high” enzymatic activity in the oxidized
disulfide state and “low” activity in the reduced sulf-
hydryl state.
In an effort to expand on this notion, cells were
treated with the oxidant, hydrogen peroxide. As seen
in Figure 7, there was a four- to five-fold increase in
nDut dimer as a function of increasing H2O2 concen-
tration. Based on the data shown in Figure 5, dUTP-
hydrolyzing activity requires an intact C-3 and pre-
sumably an intermolecular disulfide bond formation
in nDut. From these observations, it can be inferred
that increased cellular oxidative stress leads to
increased dimer formation and increased activity of
the enzyme.
Lastly, nucleotide metabolism has long been a
target for chemotherapeutics, in which drugs such as
5-fluorouracil (5-FU) and fluorodeoxyuridine (FUdR)
still continue to see substantial clinical use. They tar-
get thymidylate synthases (TS) to induce a severe
depletion of TTP pools. However, a major drawback
is the drug resistance developed with therapy for
drugs of this class. It has been reported that tumor
cells are protected from aberrant misincorporation of
uracil through the enzymatic action of dUTPase dur-
ing TS inhibition.24,25 For this reason, dUTPase has
been a target for the development of novel chemo-
therapeutic reagents.26 Thus far, the focus of drug
development has been on uracil derivatives that bind
irreversibly to the active site.12,13,27,28 When adminis-
tered they need to be used in combination with multi-
ple chemotherapeutic drugs. With this new structural
information, it may now be feasible to target nDut
activity through a different mechanism: by disrupting
its redox potential by specifically blocking the C3–C3
disulfide linkage rendering the enzyme inactive.
Materials and methods
Cloning
The open reading frame of Wt nuclear dUTPase
(Accession no. NM_001948) was cloned into the
BamHI-EcoRI restriction sites of the pProEx HTa
vector (Invitrogen, Carlsbad, CA) resulting in an N-
terminal hexahistidine tag. This includes a 28 amino
acid leader sequence (3458 Da) derived from the vec-
tor. Site-directed mutagenesis was then used with
this construct to create the cysteine to alanine, serine
to aspartic acid and serine to alanine mutants using
the primers listed in the table. The Wt and cysteine
to alanine mutants N-terminal hexahistidine tagged
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constructs were sub-cloned into the XbaI-NotI restric-
tion sites of the pCI-neo mammalian expression vec-
tor (Promega Corp., Madison, WI).
C-terminal poly-histidine tagged open reading
frames of nuclear dUTPase was constructed as fol-
lows. Utilizing the primers listed in the table, PCR
products of Wt nuclear dUTPase and all mutants
were generated containing the C-terminal tag. These
constructs were then cloned into the NotI- EcoRI
restriction sites of the pCI-neo mammalian expres-
sion vector. In contrast to the N-terminal poly-
histidine tagged nDuts, these constructs are devoid of
the vector leader sequence.
The pProExHTa containing constructs, described
above, were utilized to produce bacterially expressed
N-terminal tagged protein. To generate C-terminal
histidine tagged protein, PCR products were gener-
ated from nDut templates using the primers listed in
the table. The resulting products were cloned into the
NdeI-HindIII restriction sites of the pCW-LIC vector
(Addgene plasmid 26098). The resulting constructs
encoded the natural methionine start site and a C-
terminal histidine tag. DNA sequence analysis was
used to verify that all constructs contained the correct
open reading frames (University of Michigan DNA
sequencing core facility). Primers used for the various
cloning procedures are listed in Tables I and S1.
Site-directed mutagenesis
QuikChange II XL Site-Directed Mutagenesis Kit
(Agilent Technologies, Santa Clara, CA) was used for
all site-directed mutagenesis reactions. The standard
protocol provided by the manufacturer was followed.
The C78:134A double mutant was produced by per-
forming a second site-directed reaction on the positive
C78A clone with the primers for C134A (Table I). All
of the clones were verified via sequencing at the Uni-
versity of Michigan DNA sequencing core facility.
Recombinant protein expression and purification
Wt nuclear dUTPase and mutants were expressed in
E. coli BL21(DE3)RIPL (New England Biolabs Inc.,
Beverly, MA) for 1.5 h at 37C using 1 mM isopropyl
beta-D-1-thiogalactopyranoside (IPTG). The cells were
harvested at 6000g for 20 min at 4C. The pellet was
washed with 10 mL of PBS then frozen at −80C
overnight. The cells were suspended in Bugbuster
reagent (EMD Millipore, Billerica, MA) where the
standard company protocol was followed. Nickel col-
umn chromatography (Qiagen, Valencia, CA) was
used for purification following standard company pro-
tocol. Briefly, the column was equilibrated and
washed with “Buffer 1” consisting of 50 mM sodium
phosphate pH 7.4, 300 mM NaCl, and 10 mM
Table I. Primers for cloning and mutagenesis
Primer name Primer sequence (50 to 30)
Wt nuclear dUTPase 50-tctagaaccatgtcgtactaccatcaccatca-30
N-terminal hexahistidine tag (pProEx HTA)
Wt nuclear dUTPase 50-gcggccgcgctcgtcgacgtaggcctttgaattc-30
N-terminal hexahistidine tag Comp (pProEx HTA)
Complementary
C3A mutant (site-directed mutagenesis) 50-gggtgtctcttcagaggcgggcatcggatccatg-30
C3A mutant (site-directed mutagenesis) 50-catggatccgatgcccgcctctgaagagacaccc-30
Complementary
C78A mutant (site-directed mutagenesis) 50-gccactcttccataagccccagaagggagcgc-30
C78A mutant (site-directed mutagenesis) 50-gcgctcccttctggggcttatggaagagtggc-30
Complementary
C134A mutant (site-directed mutagenesis) 50-ataaaaaatccgttcggcaatgagctgtgcaattcgatcaccttttttg-30
C134A mutant (site-directed mutagenesis) 50-caaaaaaggtgatcgaattgcacagctcattgccgaacggattttttat-30
Complementary
Wt nuclear dUTPase, C78A,C134A, and C78;134A 50- cgcgaattcatgccctgctctgaagagacac-30
C-Terminal hexahistidine tag (pCI-neo)
Wt nuclear dUTPase, C78A,C134A, and C78;134A 50-cgcgcggccgcttaatggtgatggtgatggtgattctttccagtggaaccaaaacc-30
C-Terminal hexahistidine tag (pCI-neo)
Complementary
C3A mutant 50-cgcgaattcatgcccgcctctgaagag-30
C-Terminal hexahistidine tag (pCI-neo)
C3A mutant 50-cgcgcggccgcttaatggtgatggtgatggtgattctttccagtggaaccaaaacc-30
C-Terminal hexahistidine tag (pCI-neo)
Complementary
Wt nuclear dUTPase 50-gcgcatatgccctgctctgaagagaca30
C-Terminal hexahistidine tag
(pCW-LIC)
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imidazole. The protein was eluted with “Buffer 200
containing 50 mM sodium phosphate pH 7.4, 300 mM
NaCl, and 150 mM imidazole. The eluted fractions
containing the purified protein were pooled and then
subjected to overnight dialysis against 50 mM Tris–
HCl pH 7.5, 50 mM NaCl, and 10% glycerol. The pro-
tein, if needed, was concentrated using Amicon
Ultra115 centrifugal filter (UFC901008) using the
protocol of the manufacturer.
SDS-PAGE electrophoresis
12%, 16% and 4–20% precast TGX SDS-Page (Bio
Rad) or Novex Tris-Glycine gels (ThermoFisher Sci-
entific, Waltham, MA) were used following standard
company procedure to separate the proteins in both
reducing (1% beta-mercaptoethanol) and non-
reducing conditions. Equal amounts of protein from
each sample were prepared for SDS-PAGE by the
addition of 1 × laemmli SDS-sample buffer (4% SDS,
20% glycerol, 0.004% bromophenol blue, and 0.125 M
Tris–HCl, pH 6.8) and heated for 5 min at 85C
unless otherwise specified. For non-reducing condi-
tions, post-formaldehyde cross-linking samples were
heated to 37C for 15 min before loading the gel.
Western blot analysis
Electrophoretically separated protein was transferred
to PVDF (Bio-Rad-162-0177). Standard protocols
were used to perform the western blot analysis.29
ECL chemiluminescent western blotting detection
system (Amersham Corp., Buckinghamshire, UK)
was used to visualize the protein. Blots were exposed
to Hyblot CL autoradiography film (Denville
Scientific, Holliston, MA ) for varying times, indicated
in the figures.
Antibodies
dUTPase-specific polyclonal antibody was generated
by Covance Research Products (Denver Pennsylva-
nia) based on a recombinant protein provided by our
laboratory. DNA sequence encoding the C-terminal
portion of dUTPase (DTERGSGGFGSTGKN) was
cloned at the C-terminus of glutathione-S-transferase
(GST) of the pGEX-3X vector (GE Healthcare Life
Sciences, Chicago, IL). The fusion protein was
expressed in E. coli and purified by glutathione
sepharose affinity chromatography using standard
protocols of the manufacturer. The purified fusion
protein was shipped to Covance for antibody genera-
tion in rabbits. Purification of reactive antibody was
accomplished by antigen affinity chromatography
using a six histidine-tagged dUTPase protein linked
to cyanogen bromide-activated sepharose. The puri-
fied antibody was stored in PBS at −70C and rou-
tinely used at a dilution of 1:2000 for immunoblot
analysis. The antibody recognizes all three isoforms
of human dUTPase (Mito. dUTPase, variant 1, Acces-
sion no._001025248; Nuclear dUTPase, variant
2, Accession no. _001948; Internal start (Met24) vari-
ant 3, Accession no._001025249. Anti-His (HIS.H8)
mouse monoclonal antibody was purchased from
Thermo-Fisher Scientific (MA1-21315).
Enzyme assays
dUTPase activity was measured using a procedure
described by Caradonna and Adamkiewicz,1 with the
alteration of no reducing agent [Dithiothreitol (DTT)]
added. For the assays that compared the addition of
a reducing agent, each of the protein samples that
were tested in reducing conditions had 2% BME
added to the protein stock. All samples for this exper-
iment (BME) were allowed to incubate on ice for
15 min before performing the assay. Then an addi-
tional 2% BME was added directly to the enzyme
assay mixture for the indicated samples.
Cell culture and related protocols
Saos-2 (ATCC, HTB-85), A549 (ATCC, CCL-185),
CCD-18Co (ATCC, CRL-1459), HeLa (ATCC, CCL-2),
and U-2 OS (ATCC, HTB-96) cells were grown in Dul-
becco’s minimum essential medium (GIBCO, Carls-
bad, CA), with high glucose containing 10% fetal
bovine serum (FBS; Invitrogen, Carlsbad, CA) and
1% sodium pyruvate (GIBCO) at 37C in 5% CO2.
The cells were harvested by scraping and washed
twice with PBS. A standard extraction protocol was
followed using cell lysis buffer from Cell Signaling
Technology with the addition of 5 mM iodoacetamide
(ThermoFisher Scientific, Waltham, MA).
Transient transfection: U-2 OS cells were seeded
at 1×106 in a 60-mm dish 24 h prior to treatment.
The cells were then transiently transfected for 24 h
with 12 μL TurboFect (Thermo Fisher Inc.), 3 μg plas-
mid and 600 μL OPTI-MEM (Gibco Life Technology).
The mixture was allowed to incubate for 20 min at
room temperature before adding it directly to the
cells. Post-transfection, the cells were scraped and
washed twice with PBS. A standard extraction proto-
col was followed using cell lysis buffer from Cell Sig-
naling Technology (Boston, MA).
Formaldehyde cross-linking: U-2 OS and HeLa
cells were grown to 50–60% confluency in 175 cm2
flasks. Formaldehyde was added directly to the
medium to a final concentration of 1%. The flasks
were rocked at room temperature for 15 min and gly-
cine was added to a final concentration of 0.125 M to
quench the cross-linking reaction. Figure S2 indicates
that this percentage of formaldehyde and the time
used produced consistent cross-linked species. Nuclei
were prepared from whole cells that had been sub-
jected to formaldehyde. We found that recovery of
mitochondria from these cross-linked whole cells was
very poor. Therefore, we isolated mitochondria first
and then formaldehyde cross-linked as described
above.
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Cell fractionation for mitochondrial and nuclear
fractions: Mitochondria were isolated from U-2 OS
and HeLa cells utilizing previously published proce-
dures11 with the addition of 5 mM iodoacetamide
(ThermoFisher Scientific) added directly to the
extraction buffer. Homogenization buffer contained
0.25 M sucrose, 1 mM EDTA, 10 mM HEPES, and
0.5% BSA at pH 7.4. Protease inhibitors were added
immediately before use. Pellets derived from low-
speed centrifugation (600 g/10 min/4C) were sus-
pended in 0.1% Triton X-100/PBS, incubated on ice
for 10 min and then centrifuged. This was repeated
once and the pellet was used as the nuclear fraction.
Hydrogen peroxide treatment: U-2 OS and HeLa
cells were seeded at 1×106 in a 60-mm dish 24 h prior
to treatment. Hydrogen peroxide was added directly
to the medium to a final concentration of 0.1–0.5 mM
as indicated for 18 h at 37C. Post-treatment, the
cells were scraped and washed twice with PBS. A
standard extraction protocol was followed using cell
lysis buffer from Cell Signaling Technology
(Boston, MA).
MALDI-MS
The purified proteins used in mass spectrometry
studies were first subjected to dialysis (Pierce Slide-
A-Lyzer MINI dialysis unit) for 3 h at 4C against
100 mM ammonium bicarbonate (Sigma-Aldrich,
St. Louis, MO).
MALDI-TOF: Purified nDut.Ntag (2.0 μg) or
nDut.Ntag.C3A (2.0μg) was concentrated and
desalted using a C4 ZipTip (EMD Millipore, Billerica,
MA). The samples were then mixed at a 1:1 ratio with
saturated 2,5-dihydroxybenzoic acid matrix (Bruker)
in 50% acetonitrile (Sigma-Aldrich) and 0.1% trifluor-
oacetic acid (TFA) (Sigma-Aldrich) in LL-MS grade
water (ThermoFisher Scientific). 1 μl of the mixture
was spotted on the MALDI target plate. Positive-ion
field reflection mode was used.
MS/MS spectra were measured using Post-Source
Decay (PSD). Purified nDut.Ntag (2.0 μg) or nDut.
Ctag (2.0 μg) was alkylated for 20 min with 11 mM
iodoacetamide (ThermoFisher Scientific) in 100 mM
ammonium bicarbonate (Sigma-Aldrich). The protein
samples were then treated with 5 μl of 0.1 mg/mL
trypsin for 3 h (nDut.Ctag) or overnight (nDut.Ntag)
at 37C. The digest was concentrated and desalted
using a C18 ZipTip (EMD Millipore). The samples
were then mixed at a 1:1 ratio with 10 μg/μL CHCA
matrix (alpha-cyano-4-hydroxycinnamic acid) (Bruker)
in 50% acetonitrile (Sigma-Aldrich) and 0.1% TFA
(Sigma-Aldrich) in LL-MS grade water (ThermoFisher
Scientific). 1 μl of the mixture was spotted on the
MALDI target plate. PSD was performed in the
positive-ion mode. The range was set for nDut.Ctag at
90 Da and nDut.Ntag at 15 Da.
A Bruker MicroFlex LRF MALDI-TOF instru-
ment was used to collect all data. It has a mass
accuracy of <75 ppm in reflector mode and a resolu-
tion of >15,000 FWHM (for Somatostatin 28 (m/z
3,147.47)). The laser operates at 337 nm generating a
stable ion by a 60 Hz N2-Cartridge-Laser. The ion
gate for the precursor ion selection for PSD has a res-
olution of >100. The instrument was externally mass-
calibrated with standards purchased from Bruker.
For MALDI-TOF protein standard II was used. For
PSD peptide calibration standard II was used. All
spectra were analyzed with Flex Analysis software
(Bruker).
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